Foghorn Therapeutics Inc. revenue for the last year amounted to 34.16 M USD, the most of which — 34.16 M USD — came from its highest performing source at the moment, Medicines, the year earlier bringing 19.23 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Foghorn Therapeutics Inc. 34.16 M USD, and the year before that — 19.23 M USD.